Back to Show
PBS News Hour
Why aren't generic drugs coming to market sooner?
The FTC's recent $1.2 billion settlement over the drug Provigil has brought so-called "pay for delay" deals for generic drugs back into the spotlight. Opponents say these deals delay generic medications to market, costing consumers billions. But drug companies say that the deals help get generics to market by avoiding lengthy patent litigation. NewsHour's Megan Thompson reports.
Support Provided By
56:45
A court rejects Trump's claim of immunity with major implications for his election interference case.
26:36
Why a record number of people across America are experiencing homelessness this holiday season.
24:44
How some cities are testing no-strings-attached payment programs as a way to help lower-income residents get a leg up.
56:45
Hunter Biden's plea deal unravels over concerns about whether future charges can be brought against the president's son.
56:45
This episode is the July 19, 2023 broadcast.
56:45
Floodwaters rage and dangerous heat waves grow worse, posing serious risks to millions of Americans.
56:44
NATO leaders kick off a multi-nation summit with Ukraine seeking a path to join the expanding alliance.
56:45
A federal judge limits the Biden administration's contact with social media companies over concerns about censorship and free speech.
The global surge in energy costs is impacting millions around the world.
26:45
With monkeypox cases on the rise, concerns grow over disparities in access to vaccines, testing and treatment.
56:41
President Biden asks Congress to suspend the federal gas tax temporarily as rising prices pinch Americans nationwide.
26:38
Ukrainian officials say they've won the battle for Kyiv as Russia repositions its forces and begins a new offensive in the east.